SYS-CON MEDIA Authors: PR.com Newswire, RealWire News Distribution, Scott Kinka, Kevin Benedict, Gilad Parann-Nissany

News Feed Item

Clinverse, Inc. Announces Strategic Partnership With eClinical Insights(R)

Fully Integrated Solution Delivers Unparalleled Visibility Across eClinical Ecosystem

DURHAM, NC and CAMBRIDGE, MA -- (Marketwired) -- 05/21/14 -- Clinverse, Inc., the new standard for automating the financial lifecycle of global clinical trials, and eClinical Insights®, a leading-edge provider of cloud-based clinical trials software, announced today they have formed a strategic partnership.

Clinverse's ClinPay® solution automates sponsor payments to clinical vendors, investigators, and other parties throughout the entire financial lifecycle of a clinical trial, reducing workload and costs while improving transparency and control. The eClinical Insights integrated technology platform delivers real time visibility and control across disparate systems and diverse teams, providing actionable information through in-stream clinical trial intelligence and workflow capabilities.

"Together, we are able to offer CROs and clinical trial sponsors a best-of-breed, fully integrated solution that delivers real-time visibility across the eClinical ecosystem," said Denis Connaghan, CEO of Clinverse. "Joint customers stand to gain a measureable return on investment, increased competitive advantage, and decreased ramp-up time and learning curve."

Using the ClinPay application programming interface (API) and eClinical Insights proprietary integration framework, the integrated solution offers seamless data integration with any other clinical technology. With the financial lifecycle management of ClinPay and the combined trial management capabilities of eClinical Insights' TrialOps Director™ and inTrial Metrix™ applications, sponsors and CROs can further improve the performance of their clinical trials while substantially reducing labor costs associated with payment and accounting processes for clinical vendors and investigative sites.

"Adding Clinverse as a strategic partner in our integrated technology network enables us to expand the reach and capabilities of our platform," said Peg Regan, President & CEO of eClinical Insights. "This partnership and integrated solution fit seamlessly with our philosophy and approach to improving trial performance across a complex eClinical ecosystem."

About eClinical Insights®
eClinical Insights® is a leading-edge provider of cloud-based clinical software. The company's mission is to provide clinical research professionals with the strategic visibility to make rapid, data-driven decisions to positively impact the performance and cost of their clinical trials. The company's eClinical intelligence platform is the first of its kind in the industry, and delivers unparalleled visibility and control across the disparate systems and diverse teams being used to conduct clinical trials across the globe. eClinical Insights is headquartered in Cambridge, MA. For more information, please visit www.eclinicalinsights.com.

About Clinverse, Inc.
Clinverse, Inc. architected the industry's first end-to-end technology solution that automates the financial lifecycle of global clinical trials. Powered by our secure technology platform, our solution standardizes clinical trial finance and manages millions of financial transactions across the globe, including clinical site payments. Used by leading BioPharma companies, our clients benefit from reduced workload, time, and costs gained through automation and unprecedented transparency and workflow. For more information, please visit www.clinverse.com.

(Source: REC)

eClinical Insights Media Contact
Valerie Harding
Ripple Effect Communications
Tel: 617-536-8887
Email: Email Contact

Clinverse Media Contact:
Molly Thompson
Crossroads PR & Marketing, for Clinverse
Tel: 919.821.2822
Email: Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.